Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Zanubrutinib
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[7] 13, 48, 61, 63, 222, 300, 331 💬
2Zanubrutinib 160mg/d
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
3Zanubrutinib 240mg/d
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
4Zanubrutinib 80 MG
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 300 💬
5Zanubrutinib 80mg/d
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 63 💬
6Zanubrutinib Oral Capsule
(D11422)
[1] Zanubrutinib[1] Zanubrutinib (D11422) 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 61 💬